Journal of Addiction Medicine

Article	Citations
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine	106
Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases	73
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations	70
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report	59
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations	59
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.	48
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease	46
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes	45
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial	42
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–2019	42
Treatment of Kratom Use Disorder With Methadone in an Opioid Treatment Program	39
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language	35
GLP-1 RA Medication Associations With Hazardous Alcohol Drinking Reductions in Patients With Overweight or Obesity: A Prospective Observational Study	34
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions	32
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals	27
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study	27
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review	27
Implantable Cardioverter Defibrillator Placement to Permit Ongoing Methadone Treatment Despite QT Prolongation and Torsades de Pointes: A Case Report	25
Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder	24
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder	24
Gains in Employment Status Are Associated With Lower Methamphetamine Use Frequency at Outpatient Specialty Treatment Discharge	23
High Primary COVID-19 Vaccine Series Completion by People Who Inject Drugs When Colocating Services at a Syringe Services Van	22
Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment	21
Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States	21
Assessing Childhood Maltreatment Exposure in Patients Without and With a Diagnosis of Substance Use Disorder	21

Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys	20
Dosing and Safety of Methadone Initiation in the Setting of Fentanyl: A Systematic Review	20
Fertility Beliefs and Menstrual Experiences Among Women Entering Opioid Use Disorder Treatment	19
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19	18
Rating the Quality and Consistency of Local Opioid Settlement Expenditure Data	17
Feasibility of Emergency Department–based Fentanyl Test Strip Distribution	17
Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review	17
Use of Cannabinoids by People Who Consume Kratom in the United States	17
Identifying Areas to Improve Care and Support Parent-Child Relationships From the Perspective of Pregnant and Parenting People in Recovery	16
Clinical and Demographic Characteristics of Hospitalized Patients With Xylazine-related Wounds	16
Adolescent Tobacco/Nicotine Use and the Potential Role of Contingency Management-based Interventions	15
Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder	15
Substance Use Among US Adults at Midlife: Risk Factors and Protective Factors Among National and Milwaukee Black American Samples	15
Individuals Dispensed Buprenorphine in the United States Before and After Federal Policy Changes Aimed at Increasing Access	14
Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration	14
Approaches for Managing Benzodiazepine Dependence Arising From Use of the Adulterated Opioid Supply: A Delphi Technique	14
Complicating Factors Surrounding Concurrent Use of Kratom and a Novel 7-hydroxymitragynine Product Among a Participant Enrolled in a Kratom Clinical Trial	14
Stigmatizing Language in Substance Use-related International Classification of Diseases Codes	13
Adapting Contingency Management for Hospitalized Patients with Stimulant Use Disorder	13
A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial	13
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022	13
Fentanyl Test Strips for Harm Reduction: A Scoping Review	13
Current State of Perioperative Buprenorphine Management—A National Provider Survey	12
A Hospital-based Managed Alcohol Program in a Canadian Setting	12
Online Narcotics Anonymous: An Option for Addressing Methamphetamine Use Disorder	12
Systematic Review of Obstetric and Child Outcomes of Prenatal Exposure to Inhalants in the Context of a Use Disorder	12
The Effect of Dehydroepiandrosterone Administration during Rehabilitation on White Matter Integrity Among Individuals With Polysubstance Use Disorder	12
Public Xylazine Awareness and Support for Policies and Initiatives to Address the Xylazine Threat Among US Adults	12
Integrative Analysis of Proteome-wide Association Studies and Functional Enrichment Analysis to Identify Genes and Chemicals Associated with Alcohol Dependence	11
Trends in Buprenorphine and Methadone Initiation for Opioid Use Disorder Among Patients Using Fentanyl: A Mixed-methods Analysis From an Inpatient Addiction Consult Service	11
Utilizing the Transitional Pain Service to Provide Perioperative Contingency Management for Stimulant Use	11
Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder Treatment	11
Opioid Settlements: The Role for Addiction Medicine in Guiding Effective Spending	11
The Use of Pattern Recognition to Augment Traditional Monitoring in the Prevention of Opioid Overdose Harm	10
Insurance-related Risk Factors for Leaving Against Medical Advice after Opioid Overdose: A Cross-sectional Study Using Electronic Health Records	10
Substance-specific Mortality Risk Stratification Among Adults With Substance Use Disorders During Acute Respiratory Infection: A 3.4-Million-patient N3C Cohort Study	10
Addiction Services for Veterans: Opportunities in Acute Care	10
Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis	10
Xylazine Test Strip Use Among People Who Use Drugs in New York State	10
Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population	10
Response to: “Prevalence of Kratom Use Disorder among Kratom Consumers”	10
Too Many Pills, Too Little Attention: Emphasizing Psychotropic Polypharmacy in the Overdose Conversation	10
Clinical Presentations and Treatment of Phenibut Toxicity and Withdrawal: A Systematic Literature Review	10
The Difficulties in Finding the Relevant Associations Between Internet Gaming Disorder (IGD) and the Incidence of Suicide-Related Ideation and Behaviors in College Students	10
Perceptions of Overdose Response Hotlines and Phone Application Services Among Women and Gender-diverse Individuals Who Use Drugs in Canada: A Qualitative Study	10
Integration of Substance Use Disorder Services in Veterans Affairs Primary Care Clinics Serving Homeless Women	10
Letter in Reply	10
Climate Change and the Opioid Epidemic	10
Investigating Healthcare Provider Bias Toward Patients Who Use Drugs Using a Survey-based Implicit Association Test: Pilot Study	10
ASAM/AAAP Clinical Practice Guideline (CPG) for Stimulant Use Disorder (StUD) Management: Commentary on Research Priorities	10

Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder	10
Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation Setting	10
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method	10
Evidence of “Repeated Admission Bias” Among Those Who Use Injection Drugs Across 2 Decades of US Treatment Admissions: 2000–2020	10
Discordance Between Self-reported and Biologically Tested Exposure to Fentanyl Among People at Risk of Opioid Overdose	10
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine	9
Methadone and Torsades de Pointes: A Case Series	9
N-acetylcysteine Efficacy on Cocaine Base Paste Use Disorder: A Randomized Double-blind Placebo-controlled Clinical Trial	9
Kratom Use Among Pregnant and Lactating Individuals With Substance Use Disorder	9
Barriers and Facilitators to Accessing Opioid Agonist Therapy for Street-involved Adolescents and Young Adults in Vancouver	9
Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial	9
Community Pharmacist Perspectives on Observing and Dispensing Methadone for Opioid Use Disorder: Cross-sectional Survey Study	9
Longitudinal Patterns of Dental Health Care Utilization 18 Months Before and 36 Months After Initiation of Index Medications for Opioid Use Disorder	9
The Use of a Single Dose of Phenobarbital for Inpatient Management of Benzodiazepine Withdrawal: A Case Report	9
Aripiprazole Is Not Effective for Abstinence or Decreased Use in Alcohol and Stimulant Use Disorders in Patients Without Psychiatric Comorbidities: A Systematic Review	9
Response to "Two Clinical Insights on Methamphetamine Withdrawal at a Safety-net Hospital"	9
A Scoping Review of Youth Overdose Prevention Interventions	9
Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice	9
Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis	9
The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine	9
Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine	9
Direct Induction of Buprenorphine Extended-Release: A Case Report	9
48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine	8
Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine	8
Z-Drug Use and Benzodiazepine Use and Misuse Among LGB Populations: The Role of Psychological Distress	8
Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings	8
Prevalence of Kratom Use Disorder Among Kratom Consumers	8
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation	8
Using Machine Learning to Predict Treatment Adherence in Patients on Medication for Opioid Use Disorder	8
Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia	8
Reply to: “Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine”	8
An Institutional Provider Survey Evaluating Access and Implementation of Opioid Use Disorder Treatment in the Intensive Care Unit	8
Feasibility and Acceptability of a Pilot Contingency Management Intervention for Stimulant Use Disorder in a Hospital Setting	8
Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study	8
Factors Associated With Telehealth Buprenorphine Initiation	8
Concerns for Discharge of Persons Who Inject Drugs Home With Central Venous Catheters: A Letter to the Editor	8
Identifying Factors Associated With Intentional and Unintentional Fentanyl Use Among People Who Use Drugs in New York City	8
Validating the Waterpipe Addiction, Craving, and Anticipation Scale: An Exploratory Factor Analysis	8
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study	8
Testing the Efficacy of an Adaptive Approach to Delivering Psychosocial Interventions in Office-based Buprenorphine Treatment	8
Examining Racial/Ethnic and Income Disparities on Tobacco Product Use Among US Adults Within Wave 5 of the PATH Study	8
Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study	7
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment	7
Challenges of Drug Testing in Addiction Treatment	7
A Critical Appraisal on the Alleged Carcinogenic Potential of Sublingual Buprenorphine	7
Response to: “Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial”	7
Satisfaction With Opioid Agonist Treatment: The Compelling Need for Multidimensional, Patient-centered, Patient-reported Experience Measures	7
Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response	7
Response to Martins et al.	7
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose	7
Feasibility of a Brief Intervention to Decrease Harmful Alcohol Use Among Methadone Maintenance Treatment Clients in Shanghai: A Randomized Controlled Trial	7
Response to the Federation of State Physician Health Program's Commentary	7
Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices	7
Predictors of the Rate of Illicit Fentanyl Metabolism in a Cohort of Pregnant Individuals	7
Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics	7
Health Care Service Presence, Social Vulnerability, and Opioid Overdose Rate Acceleration: A United States, County-level Analysis, 2020–2022	7
Response to Correspondence on “Precipitated Withdrawal Following Emergency Department-initiated Buprenorphine: A Retrospective Study	7
Heterogeneity in Prescription Opioid Misuse Motives by Age in Adolescents and Young Adults in the United States	7
Opioid Use Disorder Screening Practices in US Jails	7
Case Report: Oral-Nasal Damage in a Person Using Fentanyl and Xylazine	6
Readmissions Among Patients With Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis	6
Feasibility of an Inpatient Split-Dose Rapid Methadone Induction Protocol for Pregnant Individuals	6
Cannabis and Cannabinoids for Treating Pain: What Are the Data?	6
Disruption of Opioid Treatment Program Services Due to an Extreme Weather Event: An Example of Climate Change Effects on the Health of Persons Who Use Drugs	6
Naloxone Prescribing and Naloxone Administration in Response to Overdose Events Among Women With Opioid Use Disorder During Pregnancy and Postpartum Period – MAT-LINK, Seven Clinical Sites, 2014–2021	6
Community-based Care Coordination and Treatment Retention in Opioid Use Disorder	6
Emergency Department Presentations Related to the Abuse of Illicit and Prescription Opioids Through a European Sentinel-centres–Based Registry	6
Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis	6
Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions	6
Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis	6
False-Positive Phosphatidylethanol Results Due to Blood Transfusion and Implications in the Process of Liver Transplantation Selection	6
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	6
Disparities in Buprenorphine Administration for Opioid Use Disorder in the Emergency Department	6
The Impact of Frequency of Cannabis Use on Hypertensive Disorders During Pregnancy	6
A Comparison of Neuropsychological Functioning Between Patients With Opioid Use Disorder Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone	6
Development and Validation of a High-sensitivity Rapid Xylazine Dipstick for Clinical Urine Testing	6
Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms	6
Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management	6
Use of Practices to Reduce of Sudden Unexpected Infant Death Among Caregivers of Opioid Exposed Newborns	6
Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy	6

Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder	6
Opioid Use Disorder Among the Economically Disadvantaged in the Rural South	5
The Association of Alcohol Withdrawal Severity Scales that Incorporate Vital Signs and Withdrawal Outcomes: A Multicenter Cohort Study	5
Xylazine Exposure and Association With Early Physiological and Withdrawal Symptoms in People With Opioid Use Disorder	5
Predictors of Treatment Completion in an Inpatient Substance Use Treatment Service in India	5
From Management to Maintenance: A Pilot Ambulatory Gabapentin Bridge Protocol for Treatment of Low-risk Alcohol Withdrawal Syndrome	5
Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process	5
Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape	5
The American Society of Addiction Medicine Clinical Practice Guideline Development Methodology	5
2024 ASAM Annual Conference Poster Abstracts	5
Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-Analysis	5
Benzodiazepine Tapering: Evidence Limitations and Research Recommendations	5
Medicaid Prior Authorization and Discontinuation of Buprenorphine	5
The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review	5
The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research	5
Risk of Cannabis Use Disorder in Chronic Pain: Longitudinal Links to Pain Outcomes	5
A Critique of Phenobarbital Tapers With Buprenorphine or Methadone Initiations	5
Naloxone Use During Pregnancy—Data From 26 US Jurisdictions, 2019–2020	5
Outpatient Direct Initiation of Injectable Buprenorphine in a Harm Reduction Agency and Primary Care Clinic: A Retrospective Case Series	5
Opioid Agonist Therapy for Fentanyl-Related Opioid Use Disorder: A Systematic Review	5
Ibogaine for Opioid Use Disorder: An Unrecognized Risk	5
A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool	5
Response to: “Clinician Perspectives on Barriers and Facilitators to Providing Medications for Opioid Use Disorder for Adolescents”	5
Universal Postpartum Naloxone Provision: A Harm Reduction Quality Improvement Project	5
Circumstances Around Cigarette Use after Enforced Abstinence From Smoking in an American Prison	5
Quetiapine: A Novel Additive to the Illicit Heroin Supply in Los Angeles	5
A Retrospective Cohort Study of Oral Antimicrobial Therapy Offers in Hospitalized People Who Inject Drugs Who Elect for Self-directed Discharge	5
Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report	5
Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder during Pregnancy	5
Safety and Efficacy of Rapid Methadone Titration for Opioid Use Disorder in an Inpatient Setting: A Retrospective Cohort Study	5
Prevalence and Correlates of Past-year Kratom Use Among US Adults: Findings From the 2021–2023 National Survey on Drug Use and Health	5
The First 100 Days: The Trump Administration and Changes to Addiction Policy	5
Exploring Preferences for Communication and Care Among Hospitalized Patients With Opioid Use Disorder: A Qualitative Descriptive Study	5
Does Labetalol Trigger False Positive Drug Testing Results?	5
Xylazine Positivity in Opioid-positive Drug Screens on an Inpatient Labor Unit	4
Impact of Cocaine Use Disorder History on Receipt of Guideline-indicated Medications and Therapies Following ST-elevated Myocardial Infarction	4
Integrating Ambulatory Addiction Consultation Service Into a Community Mental Health Center	4
Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOT	4
Factors Associated With the Presence of Co-occurring Pain and Substance Use Disorder Programs in Substance Use Treatment Facilities	4
Advancing Kratom Science and Regulation: A Comparative Framework With Cannabis	4
Exploring Opioid Use Disorder Outcomes by Quantitative Urinalysis: Post Hoc Analysis of a Phase 3 Randomized Clinical Trial	4
Use of Medication for Addiction Treatment Among Physicians and Pharmacists Monitored for Substance Use Disorder by One State Physician Health Program	4
Privacy, Care-seeking, and Stigma: A Qualitative Investigation of Patient Perspectives on Sharing Substance Use Disorder Treatment Records	4
Association Between Smoking Abstinence and Depression and Anxiety Symptoms After Hospital Discharge: The Helping HAND 4 Trial	4
Self-reported Xylazine Experiences: A Mixed-methods Study of Reddit Subscribers	4
Pandemics Interlaced: The Impact of the COVID-19 Pandemic on the Wellbeing of Sober Living Home Residents	4
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative	4
An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder	4
Description of Physician Champion Efforts to Expand Buprenorphine Treatment in Primary Care and Explore a Quality Implementation Measure of Success: Buprenorphine as a Percentage of All Opioids Prescr	4
Evaluation and Management of Buprenorphine Extended-Release Injection Thrombophlebitis: A Case Report	4
The Associations of Kratom (Mitragynine), Opioids, Other Substances, and Sociodemographic Variables to Drug Intoxication–related Mortality	4
An Attendance-based Contingency Management Pilot Program for Veterans Experiencing Homelessness With Stimulant-associated Cardiomyopathy in Primary Care	4
Low-dose Initiation of Buprenorphine in Hospitalized Patients Using Buccal Buprenorphine: A Case Series	4
Kava-potentiated Withdrawal in Persons Using Multiple Substances: A Case Series of Kava and Kratom Co-ingestion	4
Dutasteride as a Treatment to Support Reduced Drinking: A Randomized Placebo-Controlled Trial	4
An Open-label Pilot Study of NicoBloc as a Novel Smoking Cessation Intervention	4
Benzodiazepine Tapering: A Marathon, Not a Sprint	4
Racial Disparities in Urine Toxicology Screening Among Pregnant People Admitted to Labor and Delivery	4
Precipitated Withdrawal following Emergency Department-initiated Buprenorphine: A Retrospective Study	4
Response to: Buprenorphine Initiation, Patient Autonomy, and Informed Consent	4
Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals With an Addiction Consult Service	4
Privacy and Digital Health: Causes for Concern and a Way Forward	4
Global, Regional, and National Burdens Attributable to Drug Use Across 204 Countries and Territories Between 1990 and 2021: The Global Burden of Disease Study 2021	4
County-Level Uptake of Take-Home Methadone and Adverse Events Among Commercially Insured Individuals	4
Outpatient Rapid Titration of Slow Release Oral Morphine for the Treatment of Opioid Use Disorder in a Canadian Setting: A Case Series	4
Standard Versus Rapid Inpatient Methadone Titration for Pregnant Patients With Opioid Use Disorder: A Retrospective Cohort Study	4
Sex-specific Trends in Methamphetamine Use in the United States, 2002–2022	4
Using Digital Health Technologies to Help Manage Symptoms of Opioid Use Disorder: A Discrete Choice Experiment to Examine Patient Preferences	4
Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia	4
Isolated Kratom Use Disorder Treated With Extended-Release Buprenorphine Taper	4
Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes	4
Age-related Psychometric Dimensionality Using the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition Opioid Use Disorder Diagnostic Criteria	4
Financial Well-being and Impact on Alcohol and Mental Health Outcomes During the COVID-19 Pandemic	4
Expanding Medical Education to Include Substance Use Disorders During Pregnancy and Postpartum: Preliminary Effectiveness of a Pilot Curriculum for Medical Students	4
Early Long-Acting Buprenorphine for Opioid Use Disorder in the Setting of Acute Pain	4
Reductions in World Health Organization Risk Drinking Level Are Associated With Reductions in Alcohol Use Disorder Diagnosis and Criteria: Evidence From an Alcohol Pharmacotherapy Trial	4
Impact of X-Waiver Elimination on Post–Hospital Discharge Buprenorphine Prescribing: An Interrupted Time Series Analysis	4
Community Pharmacists’ Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder	4
National Provider Survey: Use of Naltrexone for Pregnant Individuals with Substance Use Disorders	4
Predictors of Risky Sexual Behaviors Among Female Adolescents and Young Adults Seeking Withdrawal Management Treatment: A Lifestyle-routine Activities Theory Approach	4
A Quantitative Examination of Illness Models Among People With Opioid Use Disorder Receiving Methadone Treatment	4
Development and Testing of a Peer Recovery Support Services Intervention for Retention on Medications for Opioid Use Disorder	4
“The Sky Didn’t Fall”: Patient and Clinician Experiences With Increased Buprenorphine Prescription Lengths During Pandemic-related Telehealth Expansion	4
Effect of COVID-19 on the Long-term Cardiovascular Outcomes among Patients with Alcohol Use Disorder: A Retrospective Cohort Study Including 45,842 Patients	4
The Use of Extended-Release Buprenorphine in the Treatment of Adolescent Opioid Use Disorder: A Case Series	4